- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1, NEJM 2022, n=2,539) FDA Prescribing Information - semaglutide (weekly injection, chronic weight management) FDA Prescribing Information - tirzepatide (weekly injection, chronic weight management) FDA - Medication Guides and prescribing information database (Drugs@FDA) Comparison sources MeAgain App Store listing (verified June 11, 2026) MeAgain Google Play listing (verified June 11, 2026) Shotsy App Store listing Shotsy Google Play listing Glapp App Store listing Pep App Store listing Pep Google Play listing Phaze App Store listing Phaze Google Play listing MyFitnessPal App Store listing MyFitnessPal Google Play listing Cronometer App Store listing Cronometer Google Play listing What GLP-1 Users Say After Trying Multiple Tracker Apps 4.8 out of 5 from 25K App Store ratings and the recurring theme in MeAgain reviews is comparison: people arrive after trying other trackers

So, taking it this way helps protect the medication from digestion and ensures it reaches your bloodstream, where it can then travel to the GLP-1 receptors in the brain and perform its actions
GLP-1 medications amplify this effect pharmacologically making it easier to eat less, feel satisfied sooner, and maintain a calorie deficit without relying entirely on willpower
Thats why we provide thorough training, answer any questions, and make sure you feel comfortable
You do not need to rely on someone else to inject for you